Urokinase plasminogen activator receptor: Prognostic biomaker for endometrial cancer

Endometrial adenocarcinoma is the most common gynecologic malignancy in the US. Memarzedeh et al examined whether urokinase plasminogen activator receptor (UPAR), a glycosyl-phosphatidylinositol-linked membrane protein, is a candidate diagnostic or prognostic marker for patients with cancer of the e...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 2002-08, Vol.99 (16), p.10647
Main Authors: Memarzedeh, Sanaz, Kozak, Katherine R, Chang, Lisbeth, Natarajan, Sathima
Format: Article
Language:English
Subjects:
Cancer
Gynecology
Medical research
Proteins
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endometrial adenocarcinoma is the most common gynecologic malignancy in the US. Memarzedeh et al examined whether urokinase plasminogen activator receptor (UPAR), a glycosyl-phosphatidylinositol-linked membrane protein, is a candidate diagnostic or prognostic marker for patients with cancer of the endometrium.
ISSN:0027-8424
1091-6490